STAR SPORTS MEDICINE CO., LTD. (HKEx: 01609) disclosed that on 10 September 2026 it bought back 7,100 H-shares on the Hong Kong Stock Exchange at prices ranging from HKD 107.10 to HKD 117.00, spending a total of HKD 0.79 million. The volume-weighted average price for the transaction stood at HKD 111.87 per share.

Following the repurchase, the company’s issued share capital (excluding treasury shares) decreased to 54.80 million, while treasury shares increased to 28,700. The shares acquired represent approximately 0.01% of the company’s issued share capital prior to the transaction; total issued shares remain unchanged at 54.83 million.

Under the repurchase mandate approved on 26 June 2026, the company is authorised to buy back up to 5.48 million shares. Cumulative repurchases under this mandate now total 28,700 shares, equivalent to 0.05% of the issued share capital on the mandate date.

In line with Hong Kong listing rules, STAR SPORTS MEDICINE is subject to a moratorium on issuing, selling or transferring shares until 10 October 2026. The board confirms that the repurchase complied with all applicable regulatory requirements.